Glaxosmithkline Share News (GSK)

LONDON MARKET COMMENT: Stocks Seen Lower; Ted Baker To Meet Forecasts

Glaxo Says FDA Committee Favours Mepolizumab Approval For Adults

UPDATE 1-FDA panel backs approval of GSK asthma drug in adults

(Adds details on drug, adds asthma) By Toni Clarke June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older. The panel voted 10 to

FDA panel backs approval of GSK asthma drug in adults

June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug for severe asthma in patients aged 18 and older. The panel voted 10 to 4 against approving the drug, mepolizumab, in children aged 12 to 17. <

China graft probes a tough tonic as pharma margins bounce

By Adam Jourdan SHANGHAI, June 11 (Reuters) - Sales growth is picking up speed at Chinese drugs firms, and margins are widening, in a sign that the world's second-largest pharmaceuticals market may be rebounding from a crackdown on corruption and high prices. A Reuters' analysis of mo

BUZZ-European equities: the "buy on the dips" candidates

** Several previously well-liked stocks at attractive entry points as the market recovers from an index-wide sell-off ** European equities trading higher for the first time in June : profit-taking sees brokers urging clients to buy into highest conviction ideas as market recovers ** C

Wednesday newspaper round-up: Referendum, Bank levy, Mansion House

The Government should hold a referendum on Britain's EU membership as soon as possible to end the uncertainty that the looming vote creates for businesses, according to one of the world's leading bond investors. The Pacific Investment Management Company (Pimco) said it was important for the UK to ge

One dose of cervical cancer vaccine may suffice, scientists say

LONDON, June 10 (Reuters) - A single dose of GlaxoSmithKline's human papillomavirus (HPV) vaccine could prevent the majority of cervical cancers, saving money and improving uptake of a potentially life-saving vaccination, scientists said on Wednesday. GSK's Cervarix, which targets two strai

UPDATE 1-GSK-linked investigator freed early from China jail - source

(Adds British consulate statement, GSK no comment, context) By John Ruwitch SHANGHAI, June 9 (Reuters) - A British corporate investigator linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC is to be released early from a 2 1/2-year sentence in a Chinese jail,

GSK-linked investigator to be freed early from China prison - source

By John Ruwitch SHANGHAI, June 9 (Reuters) - A British corporate investigator linked to a bribery scandal involving drugmaker GlaxoSmithKline PLC has been told he will be released early from a 2-1/2 year prison sentence in China, a person close to his family said on Tuesday. Peter Hum

MEDIA-GSK investigator Humphrey freed from China jail-FT, citing sources

-- Source link: (http://on.ft.com/1GwmWik) -- Note: Reuters has not verified this story and does not vouch for its accuracy

Mylan Launches UK Bioequivalent Alternative To Glaxo's Seretide Evohaler

BROKER RATINGS SUMMARY: WH Ireland Says Buy Horse Hill Company

BUZZ-GlaxoSmithKline ADRs hit 4-1/2 month lows on MS downgrade

** GlaxoSmithKline ADRs down 1.8 pct to lowest levels since mid-Jan after Morgan Stanley cuts stock to "equalweight" and trims its price target on stock ** Co's capital markets day "proved our optimism was misplaced" broker says as uncertainty over legacy Pharma business offsets recovery in

BUZZ-HOLD - View from the buyside: Old Mutual's Murphy buys more pharma stocks

** Pharma about to be perceived as a growth sector again, driven by drug discoveries & accelerated US FDA approvals, says Old Mutual Global Investors' Simon Murphy, who has bought more Pharma stocks in recent months ** After wave of patent losses on blockbuster products (peaked 2 yrs ago),